Recent Quotes

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

Q1 2021		Est.		Actual		Surprise
EPS				-0.060
REV				100.000K

Q4 2020		Est.		Actual		Surprise
EPS				-0.190
REV				284.715K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
SNGX	Soligenix	1.10	-0.08	-6.75%		47.3M

Soligenix Frequently Asked Questions

How do I buy Soligenix (SNGX) stock?

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Who are Soligenix's (SNGX) competitors?

Other companies in Soligenix’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX), Midatech Pharma (NASDAQ:MTP) and Brickell Biotech (NASDAQ:BBI).

What is the target price for Soligenix (SNGX) stock?

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 238.98% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Soligenix (SNGX)?

The stock price for Soligenix (NASDAQ: SNGX) is $1.18 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Soligenix (SNGX) pay a dividend?

There are no upcoming dividends for Soligenix.

When is Soligenix (NASDAQ:SNGX) reporting earnings?

Soligenix’s Q2 earnings are confirmed for after-market on August 13, 2021.

Is Soligenix (SNGX) going to split?

There is no upcoming split for Soligenix.

What sector and industry does Soligenix (SNGX) operate in?

Soligenix is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.